High-dose-rate brachytherapy monotherapy without androgen deprivation therapy for intermediate-risk prostate cancer-Reference-Cited by-同舟云学术

High-dose-rate brachytherapy monotherapy without androgen deprivation therapy for intermediate-risk prostate cancer

Published:2017-03 Issue:2 Volume:16 Page:299-305
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Patel Shyamal^ORCID,Demanes D. Jeffrey,Ragab Omar,Zhang Mingle,Veruttipong Darlene,Nguyen Kristine,Park Sang-June,Marks Leonard,Pantuck Allan,Steinberg Michael,Kamrava Mitchell

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference33 articles.

1. A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy;Zumsteg;Eur Urol,2013

2. Stratification of brachytherapy-treated intermediate-risk prostate cancer patients into favorable and unfavorable cohorts;Merrick;J Contemp Brachytherapy,2015

3. High-dose-rate prostate brachytherapy consistently results in high quality dosimetry;White;Int J Radiat Oncol Biol Phys,2013

4. The 15-year outcomes of high-dose-rate brachytherapy for radical dose escalation in patients with prostate cancer—A benchmark for high-tech external beam radiotherapy alone?;Galalae;Brachytherapy,2014

5. High dose-rate brachytherapy boost for intermediate risk prostate cancer: long-term outcomes of two different treatment schedules and early biochemical predictors of success;Helou;Radiother Oncol,2015

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiobiological meta-analysis of the response of prostate cancer to high dose rate brachytherapy;2024-07-14

2. Overview of Radiation Therapy in the Management of Localized and Metastatic Prostate Cancer;Current Urology Reports;2024-06-11

3. High-dose-rate Brachytherapy Monotherapy in Patients With Localised Prostate Cancer: Dose Modelling and Optimisation Using Computer Algorithms;Clinical Oncology;2024-06

4. 21 Gy single fraction prostate HDR brachytherapy: 5-year results of a single institution prospective pilot study;Brachytherapy;2024-05

5. Safety and efficacy associated with single-fraction high-dose-rate brachytherapy in localized prostate cancer: a systematic review and meta-analysis;Strahlentherapie und Onkologie;2023-04-24